189 related articles for article (PubMed ID: 28858837)
1. Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.
Wang F; Chen J; Dai W; He Z; Zhai D; Chen W
Acta Pharm; 2017 Sep; 67(3):357-371. PubMed ID: 28858837
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
Chen Y; Pan L; Jiang M; Li D; Jin L
Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
[TBL] [Abstract][Full Text] [Related]
3. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
4. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
6. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
[TBL] [Abstract][Full Text] [Related]
7. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice.
Puglia C; Frasca G; Musumeci T; Rizza L; Puglisi G; Bonina F; Chiechio S
Eur J Pharm Biopharm; 2012 Jun; 81(2):288-93. PubMed ID: 22504443
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
[TBL] [Abstract][Full Text] [Related]
9. N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations.
Tian C; Asghar S; Wu Y; Kambere Amerigos D; Chen Z; Zhang M; Yin L; Huang L; Ping Q; Xiao Y
Drug Deliv; 2017 Nov; 24(1):1605-1616. PubMed ID: 29063815
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers.
Chu Y; Li D; Luo YF; He XJ; Jiang MY
Molecules; 2014 Feb; 19(2):2445-57. PubMed ID: 24566313
[TBL] [Abstract][Full Text] [Related]
11. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.
Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y
Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway.
Wang F; Ye X; Zhai D; Dai W; Wu Y; Chen J; Chen W
Acta Pharm; 2020 Jun; 70(2):227-237. PubMed ID: 31955141
[TBL] [Abstract][Full Text] [Related]
13. The role of nanostructured lipid carriers and type of biopolymers on the lipid digestion and release rate of curcumin from curcumin-loaded oleogels.
Zhang J; Chuesiang P; Kim JT; Shin GH
Food Chem; 2022 Oct; 392():133306. PubMed ID: 35636193
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
[TBL] [Abstract][Full Text] [Related]
15. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.
Meng F; Asghar S; Gao S; Su Z; Song J; Huo M; Meng W; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2015 Oct; 134():88-97. PubMed ID: 26162977
[TBL] [Abstract][Full Text] [Related]
16. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-Loaded Nanostructured Lipid Carrier Modified with Partially Hydrolyzed Ginsenoside.
Selvaraj K; Yoo BK
AAPS PharmSciTech; 2019 Jul; 20(6):252. PubMed ID: 31300965
[TBL] [Abstract][Full Text] [Related]
18. An EGF- and Curcumin-Co-Encapsulated Nanostructured Lipid Carrier Accelerates Chronic-Wound Healing in Diabetic Rats.
Lee HJ; Jeong M; Na YG; Kim SJ; Lee HK; Cho CW
Molecules; 2020 Oct; 25(20):. PubMed ID: 33050393
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside improves physicochemical properties and bioavailability of curcumin-loaded nanostructured lipid carrier.
Vijayakumar A; Baskaran R; Maeng HJ; Yoo BK
Arch Pharm Res; 2017 Jul; 40(7):864-874. PubMed ID: 28712035
[TBL] [Abstract][Full Text] [Related]
20. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
